Skip to content

Clinical trials

Phase 2 Breast Neoplasms trials in India

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Phase 2 Country / region: India Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20042
20053
20062
20074
20083
20092
20102
20113
20121
20132
20151
20172
20192
20201
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29
Terminated3
Active, not recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
Hoffmann-La Roche3
Pfizer3
AstraZeneca2
Eli Lilly and Company2
GlaxoSmithKline2
Post Graduate Institute of Medical Education and Research, Chandigarh2
Puma Biotechnology, Inc.2
Tata Memorial Hospital2
Amgen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms35
Neoplasm Metastasis5
Neoplasms5
Recurrence2
Sarcoma2
Biliary Tract Neoplasms1
Brain Neoplasms1
Carcinoma, Non-Small-Cell Lung1
Colorectal Neoplasms1
Hereditary Sensory and Autonomic Neuropathies1

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.